References
Chez, M. G., Burton, Q., Dowling, T., Chang, M., Khanna, P., & Kramer, C. (2007). Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: An observation of initial clinical response and maintenance tolerability. Journal of Child Neurology, 22(5), 574–579.
Corti, S., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Simone, C., et al. (2010). Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis. Human Molecular Genetics, 19(19), 3782–3796.
Danbolt, N. C. (2001). Glutamate uptake. Progress in Neurobiology, 65(1), 1–105.
Ghanizadeh, A. (2010a). Transplantation of GABAergic cell line as a novel hypothesized treatment for autism. Epilepsy & Behavior, 19(4), 664.
Ghanizadeh, A. (2010b). Targeting neurotensin as a potential novel approach for the treatment of autism. Journal of Neuroinflammation, 7, 58.
Ghanizadeh, A. (2011). Targeting of glycine site on NMDA receptor as a possible new strategy for autism treatment. Neurochemical Research. doi:10.1007/s11064-010-0381-2.
Harada, M., Taki, M. M., Nose, A., Kubo, H., Mori, K., Nishitani, H., et al. (2010). Non-invasive evaluation of the GABAergic/Glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument. Journal of Autism and Developmental Disorders. [Epub ahead of print].
Maragakis, N. J., & Rothstein, J. D. (2001). Glutamate transporters in neurologic disease. Archives of Neurology, 58(3), 365–370.
Niederhofer, H. (2007a). Glutamate antagonists seem to be slightly effective in psychopharmacologic treatment of autism. Journal of Clinical Psychopharmacology, 27(3), 317–318.
Niederhofer, H. (2007b). Treating autism pharmacologically: also tacrine might improve symptomatology in some cases. Journal of Child Neurology, 22(8), 1054; author reply 1054–1055.
Robinson, M. B. (1998). The family of sodium-dependent glutamate transporters: A focus on the GLT-1/EAAT2 subtype. Neurochemistry International, 33(6), 479–491.
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., et al. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron, 16(3), 675–686.
Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., Tsuchiya, K. J., et al. (2006). Increased serum levels of glutamate in adult patients with autism. Progress in Neuropsychopharmacology and Biological Psychiatry, 30(8), 1472–1477.
Silverman, J. L., Tolu, S. S., Barkan, C. L., & Crawley, J. N. (2010). Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology, 35(4), 976–989.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ghanizadeh, A. c-Kit+ Cells Transplantation as a New Treatment for Autism, a Novel Hypothesis with Important Research and Clinical Implication. J Autism Dev Disord 41, 1591–1592 (2011). https://doi.org/10.1007/s10803-010-1174-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10803-010-1174-9